close icon

Glencore’s Subpoena Plunge in Elliott Wave Context

Glencore, the world’s largest cobalt miner, plunged by as much as 13% in intraday trading on Tuesday after the news spread that the company has received a subpoena from the U.S. Department of Justice. Authorities are requesting documents regarding Glencore’s business in Congo, Venezuela and Nigeria as the company is under suspicion of corrupting government officials in the three countries to win contracts.

However, analysts at Barclays and Credit Suisse pointed out that such requests are actually quite common. Glencore has not been found guilty of anything yet and the sharp selloff in its share price looks like an overreaction by investors.

This makes us wonder why did the market react so violently to something which might or might not be such a big deal. Ralph Nelson Elliott once wrote that “the habit of the market is to anticipate, not to follow.” Was the market already anticipating bad news in the days leading to the current plunge? In order to find out, we need to put it into Elliott Wave context.
Glencore Elliott wave analysis
The daily chart allows us see Glencore’s rally from 66.7 GBp in September 2015 to as high as 416.9 GBp in early-2018. It could easily be seen as a five-wave impulse pattern with an extended third wave, whose sub-waves are also clearly visible. This means the current subpoena-inspired crash must be part of the three-wave correction, which naturally follows every impulse. It looks like the stage was, indeed, set for a decline. Glencore stock was supposed to drop with or without the DOJ investigation. In this respect, the subpoena is only a catalyst for what had to happen anyway.

Now, the next support lies near the termination area of wave (iv) of 3. This leaves the door open for the bears to drag the share price to possibly 270 pence in wave C in the short term. The long-term outlook, on the other hand, remains positive, because according to the theory the uptrend should be expected to resume as soon as wave (2/B) is over.

Did you like this analysis? Learn to do it yourself with our eBook Elliott Wave guide!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Three Months Ahead of NovoCure ‘s 35% Plunge

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that the tumor treatment company was not only significantly overvalued, but in immediate danger of a large stock price drop. The stock had just fell 15% in one day, despite positive TTFields…

Read More »

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

Match ‘s SP500 Inclusion a Good Excuse to Reach $200

Match Group Inc. rose over 10% in post-market trading Friday following reports that it is going to be included in the S&P 500. The company, which owns Tinder, OkCupid and most other major dating apps in the U.S., has a market cap of over $41B. Despite the anticipated “summer of love”, though, this is not…

Read More »

Cameco Stock Seems to Have Finally Turned a Corner

Uranium spot prices are on the verge of breaking above $34/lb, up over 80% from the bottom of $18/lb reached in late-2016. Cameco, as one of the world’s top uranium producers, is now seeing its stock price rising in tandem. Yesterday, it closed at $19.16 after reaching $21.95 in June. We first covered Cameco in…

Read More »

A Fresh Look At Cigna ‘s Elliott Wave Super Cycle

In a case study article on Cigna, published in October, 2016, we examined how a fundamentally sound and undervalued stock can still drop nearly 90%. The reason for that crash didn’t lie in some company specific issue. Rather it happened to occur during the biggest financial crisis in 80 years. Nevertheless, we made the point…

Read More »

CBOE Takeover Rumor Lifts Stock to Elliott Wave Target

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and was hovering at new all-time highs. CBOE, in contrast, was still down 30% from its 2018 record, trading below $97 a share. For some reason, the market was ignoring the company’s…

Read More »

More analyses